世界の平滑筋肉腫切除術のベスト医師 — TOP 31

准教授のエスラ・オズバシリ博士は、産婦人科における _doctor_8319_ 年以上の専門的な経験を持ち、平滑筋肉腫の低侵襲切除術に注力しています。

• 2013年よりda Vinciシステムを用いたロボット支援手術の訓練を受けている
• 子宮筋腫や腫瘍の切除のための高度な腹腔鏡手術および子宮鏡手術を実施
• 産婦人科専門医に外科的手技を指導する准教授
• 権威ある国際的な学術誌に多数の論文を発表

ソラスキー医療センター軟部組織・骨腫瘍科部長。41 年以上の専門的経験を持ち、肉腫治療を専門とする。

• パリのギュスターヴ・ルッシ研究所にて肉腫のフェローシップ修了
• ESMO（欧州臨床腫瘍学会）軟部組織・骨肉腫部門ファカルティメンバー
• 肉腫の治療法と治療成績に関する多数の論文を発表
• 倫理委員会および腫瘍学研究イニシアチブを主導

メフメット・カラジャ教授は、平滑筋肉腫を含む婦人科がんを専門とし、婦人科腫瘍外科の専門訓練を受けています。

• 産婦人科における_doctor_9114_年以上の経験
• がん治療のための腹腔鏡下手術を専門とする
• アンタルヤ教育研究病院の元臨床部長
• 現在はメディカルパーク・アンタルヤ病院複合施設に勤務

平滑筋肉腫の切除を専門とし、ハジェテペ大学がん研究所およびMDアンダーソンがんセンターで研修を受けました。

• 軟部組織肉腫の複雑な症例に対応
• 世界トップクラスのがんセンターでフェローシップを修了
• JCI認定施設にて、高度な腫瘍科ユニットで勤務

ペキゼ・エケル・バルジオグル医師は、ヒサール・ホスピタル・インターコンチネンタルにて、患者一人ひとりに合わせたアプローチを重視した外科治療を専門としています。

• イスタンブール大学ジェラフパシャ医学部卒業
• マルマラ大学にて一般外科のレジデント課程を修了
• 国内外の多数の医学会議に参加
• 国内外の学術誌に論文を掲載

ハビエル・センテノ・フォルニエス医師は、権威あるメイヨー・クリニックで大腸外科の訓練を受けました。これは平滑筋肉腫を正確に切除するための重要なスキルです。1993年以来、Centro Médico Teknonの主要な専門医を務めています。

• _doctor_8374_年_ 複雑な消化器外科手術の専門
• メイヨー・クリニックでのフェローシップ研修 – 外科的精度のゴールドスタンダード
• ERAS-Societyによる術後回復強化プロトコルの認定
• 米国大腸肛門外科学会会員

ダン・グリザロ教授は、平滑筋肉腫を含む婦人科がんを専門とし、卵巣がんおよび子宮頸がんに対する標的療法に関する広範な研究を行っています。

• スラスキー医療センター産婦人科部長
• トロント大学婦人科腫瘍学フェローシップ修了
• 83本の科学論文と39回の学会発表の著者
• 米国婦人科腫瘍学会会員

ドロール・レビン医師は、イスラエル有数の病院であるソラスキー医療センターにて、小児の骨および軟部組織肉腫の治療を専門としています。

• ソラスキー小児血液腫瘍科部長
• 腫瘍整形外科と連携した肉腫治療の調整
• 世界をリードするボローニャのリッツォーリ整形外科研究所で研修
• イスラエル小児血液腫瘍学会会員

アミール医師は、平滑筋肉腫を含む肉腫治療を専門としており、外科腫瘍学における功績で数々の賞を受賞しています。

• 米国国立がん研究所にて整形外科腫瘍学の研修を修了
• トロント大学にて整形外科腫瘍学のフェローシップを修了
• 米国筋骨格腫瘍学会および結合組織腫瘍学会の会員
• 外科腫瘍学における卓越した業績に対しタネンバウム助成金を授与

セリン・カパン教授は、_doctor_10984_年以上の外科的経験を持ち、İstinye University Liv Hospital Topkapıにて複雑な軟部組織腫瘍の切除を専門としています。

• 外科的手法に関する広範な研究を行う一般外科教授
• 国内外の学術誌に50本以上の論文を発表
• トルコ肝胆膵外科学会会員
• 腫瘍切除のための低侵襲アプローチを専門とする

アレムダル医師は、メディカルパーク・アンタルヤ病院コンプレックスにて、複雑な肉腫症例に重点を置いた腫瘍内科を専門としています。

• 2018年より腫瘍内科の認定医
• 腫瘍学における_doctor_9570_年以上の経験
• 主要な医療機関であるアクデニズ大学で研修
• 肉腫に対する高度な治療プロトコルを実践

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

ロボット支援および腹腔鏡下泌尿器科手術を専門とし、Medipol Acibadem District病院にて平滑筋肉腫切除のための高度な技術を提供。

• 2012年以来、泌尿器科における豊富な経験を持つ准教授
• 130以上の国内外の出版物
• 欧州泌尿器科学会およびその他の権威ある学会の会員
• ミシガン大学泌尿器科で研修
• Alpay Kelami男性性健康賞受賞

フィリッピーニ教授は高度な腫瘍外科を専門とし、局所進行腫瘍の治療および多臓器切除において46 年以上の経験を有しています。

• 米国の主要ながんセンターであるメモリアル・スローン・ケタリングおよびシティ・オブ・ホープで研修
• 複雑な症例に対する低侵襲およびロボット手術の専門家
• キエーティ大学教授として次世代の外科医を育成
• 腫瘍外科に関する100本以上の科学論文を発表

パヴェウ・グロホヴィッチ医師（MD, PhD）は、約40年の経験を持つ肛門科医です。聖エリザベス病院のワルシャワ肛門科センターに勤務しています。痔、肛門瘻、肛門周囲膿瘍、肛門裂傷、便失禁、毛巣嚢胞の治療を行っています。また、大腸内視鏡検査や大腸ポリープ切除術も実施しています。

1979年から2016年まで、ポーランドで唯一の専門センターであるソレツ病院の肛門科ユニットに勤務していました。2016年からは聖エリザベス病院のワルシャワ肛門科センターに勤務しています。そこで新しい治療法の開発と導入を行い、診断、リハビリテーション、研究、教育活動を行っています。同センターはポーランド大腸肛門病クラブの本部でもあります。

学術・研究職：ポーランド科学アカデミー実験臨床医学研究所（1979–1997年）。ミュンヘン大学DAAD奨学生（1983–1984年）。オーストラリア、ニューカッスル大学ジョン・ハンター病院（1989–1996年）。同病院では移植研究ユニットのディレクターおよび主任科学官を務めました（1991–1996年）。

プシェミスワフ・チェシェルスキ医師は一般外科医です。2008年に専門医課程を修了しました。1999年にワルシャワ医科大学を卒業しました。2010年に医学博士号を取得しました。彼の論文は、大腸がんのリスクが高い患者における大腸疾患を診断するための臨床検査および直腸鏡検査を評価したものです。

彼の肛門科および大腸外科のトレーニングには、正式なコースやフェローシップが含まれます。2021年と2022年にヴェルチェッリの聖ロタ病院で、2016年にケルンで肛門科コースを修了しました。2014年にウィーン医科大学、2015年にマクデブルク大学で一般外科の臨床フェローシップを務めました。2005年から2013年まで、ワルシャワのソレック病院肛門科で複数のフェローシップを経験しました。ポズナンとウッチで開催された高度な大腸外科ワークショップに参加しました。また、ロンドンのセントマークス病院で「大腸疾患の最前線」や「高度大腸外科ワークショップ」などのコースも修了しています。